Growth expansion ProcDNA is rapidly expanding its global footprint with new offices in Bengaluru and Gurugram, India, signaling ongoing capacity growth and potential needs for scalable delivery, local compliance, and regional governance services to support multi-site operations.

Pharma focus With a specialized life sciences orientation and partnerships in analytics, data, and technology, ProcDNA presents opportunities to expand offerings around clinical data analytics, real-world evidence, and AI/ML-driven insights for drug development and commercialization.

Partner ecosystem Recent collaboration with Xactly as an implementation partner indicates openness to third-party alliances; this creates a channel path for joint solutions in sales performance, incentive compensation, and MedTech analytics.

Conference intelligence Launch of 2026 Conference Intelligence capabilities suggests a sellable capability for life sciences customers seeking to extract value from major conferences, offering services around data capture, insights, and competitive benchmarking.

Tech stack readiness A mature analytics and cloud stack (Qlik, AWS, SageMaker, Azure, Jenkins) positions ProcDNA to offer end-to-end data engineering, AI/ML model deployment, and scalable analytics services to biotech and pharma clients facing data democratization and speed-to-insight needs.